Draft:Sylvie Trottier
 | This article, Draft:Sylvie Trottier, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Preload talk Inform author |
| This article, Draft:Sylvie Trottier, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Preload talk Inform author |
Sylvie Trottier | |
|---|---|
| Born | May 20, 1952 Quebec City, Canada |
| Alma mater | Laval University (BSc & MSc) University of Göteborg (Fellow, Infectious Diseases) |
| Known for | Clinical research in infectious diseases, HIV/AIDS and comorbidities, HPV, vaccines, Infection prevention and control in healthcare settings. |
| Scientific career | |
| Fields | Infectious Diseases |
| Institutions | Laval University CHU de Quebec Research Center |
Sylvie Trottier is a Canadian physician and a medical researcher in the field of infectious diseases, with a focus on HIV/AIDS. She is known for her clinical work and participation in multicentre clinical trials on viral infections and other infectious diseases.
Education
[edit | edit source]Trottier obtained two undergraduate degrees from Laval University: a Bachelor of Science in Microbiology in 1975 and a Bachelor of Science in Biochemistry in 1976. She completed a Master’s degree in Medical Microbiology in 1978 under the supervision of Michel G. Bergeron.
She earned her medical degree (MDCM) from McGill University in 1982 and subsequently returned to Laval University for a residency in infectious diseases, completed in 1985.
In 1985, Trottier undertook postdoctoral training at the University of Göteborg in Sweden, where she worked with Catharina Svanborg-Edén on mucosal immunity and bacterial pathogenesis. In this context, she co‑authored a study on germ transmission in daycare settings, describing colonization dynamics of nontypeable Haemophilus influenzae in healthy children.[1]
Career
[edit | edit source]Trottier joined the Québec Heart and Lung Institute (IUCPQ) and the CHU de Québec – Université Laval (CHUL) in 1986, at the beginning of the HIV/AIDS pandemic in Quebec. She became involved in the care of people living with HIV and in clinical research related to HIV and other infectious diseases within these institutions.
In 1995, she was appointed Chief of Clinical Research at the Infectious Disease Research Centre (Centre de recherche en infectiologie, CRI) of Laval University. The same year, she became director of the “Unité hospitalière de recherche, d’enseignement et de soins sur le sida” (UHRESS) at CHUL, a multidisciplinary HIV/AIDS unit providing specialized care, research and teaching for patients from Eastern Quebec. From 1999 to 2015, she served as Director of the Clinical Laboratories at IUCPQ. She was Director of the Department of “Microbiologie‑Infectiologie et Immunologie” in the Faculty of Medicine at Laval University from 2011 to 2019.
Research
[edit | edit source]Trottier has participated as a clinical investigator in national and international clinical trials in HIV, influenza, herpesvirus infections, Clostridioides difficile infection and other communicable diseases.[2] Her co‑authored work includes randomized trials on influenza antivirals, herpes antivirals and HIV antiretroviral strategies, as well as studies on C. difficile diagnosis and infection control. She contributed to large international HIV studies such as the SMART trial on antiretroviral therapy strategies.[3]
During the COVID‑19 pandemic, Trottier and collaborators examined SARS‑CoV‑2 infection and immune response in at‑risk essential workers in Quebec, including retail workers. Their work addressed infection rates and risk factors at the onset of the pandemic.[4][5]
According to Google Scholar, her publications have received more than 9,000 citations, with several hundred citations per year in recent years.[6] Her cited work covers HIV, respiratory viruses, bacterial infections and vaccine or antiviral evaluations.
Awards and honors
[edit | edit source]- 2008 - Farha Foundation Award « Hommage aux Héros » in recognition of 20 years of fighting HIV/AIDS and caring for patients.[7]
- 2019 - Laureate of the Council of physicians, dentists and pharmacists (CMDP of IUCPQ) category « Qualité de l’acte » (Best in Patients’ Safety).
- 2023 - CHU de Quebec Research Center Awards “Prix Découverte” - Best Collaborative Group.[8]
- 2025 - CHU de Québec Research Center Awards "Prix Recherche-Carrière".[9]
References
[edit | edit source]- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
See also
[edit | edit source]Lua error in Module:Authority_control at line 153: attempt to index field 'wikibase' (a nil value).